Works matching DE "IMMUNE checkpoint inhibitors"


Results: 5000
    1
    2
    3

    Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma.

    Published in:
    Liver International, 2025, v. 45, n. 6, p. 1, doi. 10.1111/liv.70121
    By:
    • Artusa, Fabian;
    • Lamatsch, Sven;
    • Phan, Minh Duc;
    • Özdirik, Burcin;
    • Berger, Hilmar;
    • Egerer, Mara;
    • Knorr‐Klocke, Jana;
    • Fischer, Janett;
    • Veelken, Rhea;
    • van Bömmel, Florian;
    • Berg, Thomas;
    • Kappert, Kai;
    • Tauber, Rudolf;
    • Puengel, Tobias;
    • Engelmann, Cornelius;
    • Demir, Münevver;
    • Tacke, Frank;
    • Mohr, Raphael
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    ADCs and TCE in SCLC Therapy: The Beginning of a New Era?

    Published in:
    Current Oncology, 2025, v. 32, n. 5, p. 261, doi. 10.3390/curroncol32050261
    By:
    • Muscolino, Paola;
    • Omero, Fausto;
    • Speranza, Desirèe;
    • Infurna, Carla;
    • Parisi, Silvana;
    • Cianci, Vincenzo;
    • Berretta, Massimiliano;
    • Russo, Alessandro;
    • Santarpia, Mariacarmela
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43

    Mechanisms of drug resistance in hepatocellular carcinoma.

    Published in:
    Biological Procedures Online, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s12575-025-00281-6
    By:
    • Zou, Yongchun;
    • Wan, Xinliang;
    • Zhou, Qichun;
    • Zhu, Gangxing;
    • Lin, Shanshan;
    • Tang, Qing;
    • Yang, Xiaobing;
    • Wang, Sumei
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50